Skip to Main Content

Author Details

Arun S Singh
University of California-Los Angeles
2006
94
30
PMIDPaper TitleJournal TitlePublished Year
36402606Use of neoadjuvant pexidartinib with limb salvage surgery for diffuse tenosynovial giant cell tumor: A case report.J Orthop Sci2024
36136304Preclinical and Clinical Trial Results Using Talazoparib and Low-Dose Chemotherapy.Clin Cancer Res2023
37292676The landscape of drug sensitivity and resistance in sarcoma.bioRxiv2023
37156551Immunotherapy resistance driven by loss of NY-ESO-1 expression in response to transgenic adoptive cellular therapy with PD-1 blockade.J Immunother Cancer2023
37032292The Role of Denosumab in the Treatment of Primary Tumors of Bone.J Hand Surg Am2023
36581724Lifelong Imaging Surveillance is Indicated for Patients with Primary Retroperitoneal Liposarcoma.Ann Surg Oncol2023
36690841ASO Visual Abstract: Lifelong Imaging Surveillance is Indicated for Patients with Primary Retroperitoneal Liposarcoma.Ann Surg Oncol2023
34716196Results from Phase I Extension Study Assessing Pexidartinib Treatment in Six Cohorts with Solid Tumors including TGCT, and Abnormal CSF1 Transcripts in TGCT.Clin Cancer Res2022
35705558Clinical genomic profiling in the management of patients with soft tissue and bone sarcoma.Nat Commun2022
35307963Retrospective analysis of adjuvant treatment for localized, operable uterine leiomyosarcoma.Cancer Med2022
35264439Spatial profiling reveals association between WNT pathway activation and T-cell exclusion in acquired resistance of synovial sarcoma to NY-ESO-1 transgenic T-cell therapy.J Immunother Cancer2022
34407970A Randomized Phase II Study of Nivolumab Monotherapy or Nivolumab Combined with Ipilimumab in Patients with Advanced Gastrointestinal Stromal Tumors.Clin Cancer Res2022
33400014Translating Knowledge About the Immune Microenvironment of Gastrointestinal Stromal Tumors into Effective Clinical Strategies.Curr Treat Options Oncol2021
33620515Kaposi sarcoma in anti-neutrophil cytoplasmic antibody-associated vasculitis: a case-based review.Rheumatol Int2021
35018061Assessment of Anxiety Associated with the Dental Treatments on the Quality of Life: An Original Research.J Pharm Bioallied Sci2021
34484648Aggressive osteoblastoma with a secondary aneurysmal bone cyst treated with denosumab.Rare Tumors2021
34115928T-LAK cell-originated protein kinase (TOPK): an emerging prognostic biomarker and therapeutic target in osteosarcoma.Mol Oncol2021
32381487A Phase 1b Dose Escalation Trial of NC-6300 (Nanoparticle Epirubicin) in Patients with Advanced Solid Tumors or Advanced, Metastatic, or Unresectable Soft-tissue Sarcoma.Clin Cancer Res2020
32054730A Phase II Trial of 5-Day Neoadjuvant Radiotherapy for Patients with High-Risk Primary Soft Tissue Sarcoma.Clin Cancer Res2020
31821732Pharmacokinetics of doxorubicin following concomitant intravenous administration of olaratumab (IMC-3G3) to patients with advanced soft tissue sarcoma.Cancer Med2020
32846908Chemotherapy and Survival in Patients with Primary High-Grade Extremity and Trunk Soft Tissue Sarcoma.Cancers (Basel)2020
32755981Low Rates of Chemotherapy Use for Primary, High-Grade Soft Tissue Sarcoma: A National Cancer Database Analysis.J Natl Compr Canc Netw2020
32282650Primary Renal Ewing Sarcoma in Children and Young Adults.J Pediatr Hematol Oncol2020
30573690A Pilot Trial of the Combination of Transgenic NY-ESO-1-reactive Adoptive Cellular Therapy with Dendritic Cell Vaccination with or without Ipilimumab.Clin Cancer Res2019
31687646Use of Denosumab in Children With Osteoclast Bone Dysplasias: Report of Three Cases.JBMR Plus2019
30024282Patterns of sensitivity to a panel of drugs are highly individualised for undifferentiated/unclassified soft tissue sarcoma (USTS) in patient-derived orthotopic xenograft (PDOX) nude-mouse models.J Drug Target2019
31436746Oncologic Accuracy of Image-guided Percutaneous Core-Needle Biopsy of Peripheral Nerve Sheath Tumors at a High-volume Sarcoma Center.Am J Clin Oncol2019
31264439TNS1-ALK Fusion in a Recurrent, Metastatic Uterine Mesenchymal Tumor Originally Diagnosed as Leiomyosarcoma.Acta Med Acad2019
30913092Pathologic Response to Neoadjuvant Therapy is Associated With Improved Long-term Survival in High-risk Primary Localized Malignant Peripheral Nerve Sheath Tumors.Am J Clin Oncol2019
31173362Overall survival and histology-specific subgroup analyses from a phase 3, randomized controlled study of trabectedin or dacarbazine in patients with advanced liposarcoma or leiomyosarcoma.Cancer2019
28681998Eribulin regresses a doxorubicin-resistant Ewing's sarcoma with a FUS-ERG fusion and CDKN2A-deletion in a patient-derived orthotopic xenograft (PDOX) nude mouse model.J Cell Biochem2018
30166061Combination therapy of tumor-targeting Salmonella typhimurium A1-R and oral recombinant methioninase regresses a BRAF-V600E-negative melanoma.Biochem Biophys Res Commun2018
30002809Tenosynovial giant cell tumor: case report of a patient effectively treated with pexidartinib (PLX3397) and review of the literature.Clin Sarcoma Res2018
30126369Trabectedin arrests a doxorubicin-resistant PDGFRA-activated liposarcoma patient-derived orthotopic xenograft (PDOX) nude mouse model.BMC Cancer2018
29932244Tumor-targeting Salmonella typhimurium A1-R arrests a doxorubicin-resistant PDGFRA-amplified patient-derived orthotopic xenograft mouse model of pleomorphic liposarcoma.J Cell Biochem2018
30060824Doxorubicin-resistant pleomorphic liposarcoma with PDGFRA gene amplification is targeted and regressed by pazopanib in a patient-derived orthotopic xenograft mouse model.Tissue Cell2018
30003151Tumor-targeting <i>Salmonella typhimurium</i> A1-R suppressed an imatinib-resistant gastrointestinal stromal tumor with c-kit exon 11 and 17 mutations.Heliyon2018
30292411A combination of irinotecan/cisplatinum and irinotecan/temozolomide or tumor-targeting Salmonella typhimurium A1-R arrest doxorubicin- and temozolomide-resistant myxofibrosarcoma in a PDOX mouse model.Biochem Biophys Res Commun2018
30392912Metabolic targeting with recombinant methioninase combined with palbociclib regresses a doxorubicin-resistant dedifferentiated liposarcoma.Biochem Biophys Res Commun2018
30673664Combining Tumor-Selective Bacterial Therapy with Salmonella typhimurium A1-R and Cancer Metabolism Targeting with Oral Recombinant Methioninase Regressed an Ewing's Sarcoma in a Patient-Derived Orthotopic Xenograft Model.Chemotherapy2018
30309504Tumor-targeting Salmonella typhimurium A1-R overcomes partial carboplatinum-resistance of a cancer of unknown primary (CUP).Tissue Cell2018
30275182Oral Recombinant Methioninase Combined with Caffeine and Doxorubicin Induced Regression of a Doxorubicin-resistant Synovial Sarcoma in a PDOX Mouse Model.Anticancer Res2018
29384032Individualized doxorubicin sensitivity testing of undifferentiated soft tissue sarcoma (USTS) in a patient-derived orthotopic xenograft (PDOX) model demonstrates large differences between patients.Cell Cycle2018
29721200Recombinant methioninase combined with doxorubicin (DOX) regresses a DOX-resistant synovial sarcoma in a patient-derived orthotopic xenograft (PDOX) mouse model.Oncotarget2018
29664796Long-term Outcomes With Ifosfamide-based Hypofractionated Preoperative Chemoradiotherapy for Extremity Soft Tissue Sarcomas.Am J Clin Oncol2018
29541401Intra-tumor L-methionine level highly correlates with tumor size in both pancreatic cancer and melanoma patient-derived orthotopic xenograft (PDOX) nude-mouse models.Oncotarget2018
29713497Patient-derived orthotopic xenograft models for cancer of unknown primary precisely distinguish chemotherapy, and tumor-targeting <i>S. typhimurium</i> A1-R is superior to first-line chemotherapy.Signal Transduct Target Ther2018
29374999Tumor-targeting Salmonella typhimurium A1-R combined with recombinant methioninase and cisplatinum eradicates an osteosarcoma cisplatinum-resistant lung metastasis in a patient-derived orthotopic xenograft (PDOX) mouse model: decoy, trap and kill chemotherapy moves toward the clinic.Cell Cycle2018
29737543Temozolomide regresses a doxorubicin-resistant undifferentiated spindle-cell sarcoma patient-derived orthotopic xenograft (PDOX): precision-oncology nude-mouse model matching the patient with effective therapy.J Cell Biochem2018
29481803Tumor-targeting Salmonella typhimurium A1-R is a highly effective general therapeutic for undifferentiated soft tissue sarcoma patient-derived orthotopic xenograft nude-mouse models.Biochem Biophys Res Commun2018
  • 1 - 50 of 94

Recommended Authors

Wendong Zhang
University of Texas MD Anderson Cancer Center
Career Start Year 2007
Number of shared co-authors 1
Kjetil Boye
Oslo University Hospital
Career Start Year 2007
Number of shared co-authors 0
Christian F Meyer
Johns Hopkins University School of Medicine
Career Start Year 2005
Number of shared co-authors 4
Joseph A Ludwig
The University of Texas MD Anderson Cancer Center
Career Start Year 2005
Number of shared co-authors 4
Sandra J Strauss
University College London, Cancer Institute
Career Start Year 2003
Number of shared co-authors 0
Bernadette Liegl-Atzwanger
Diagnostic and Research Institute of Pathology, Medical University of Graz
Career Start Year 2003
Number of shared co-authors 3
Sung Wook Seo
Samsung Medical Center, Sungkyunkwan University
Career Start Year 2001
Number of shared co-authors 0
Chantal Pauli
University Hospital Zurich
Career Start Year 2001
Number of shared co-authors 2
Jilong Yang
Tianjin Medical University Cancer Institute and Hospital
Career Start Year 2000
Number of shared co-authors 2
Elizabeth G Demicco
Mount Sinai Hospital and Laboratory Medicine and Pathobiology, University of Toronto
Career Start Year 2000
Number of shared co-authors 3
Angela C Hirbe
Washington University School of Medicine and Siteman Cancer Center
Career Start Year 1999
Number of shared co-authors 0
David J Liewehr
Center for Cancer Research
Career Start Year 1999
Number of shared co-authors 0
Isabelle Ray-Coquard
University Claude Bernard Lyon I
Career Start Year 1997
Number of shared co-authors 3
Nam Bui
Stanford University
Career Start Year 1996
Number of shared co-authors 2
Richard Gorlick
University of Texas MD Anderson Cancer Center
Career Start Year 1995
Number of shared co-authors 4
Jonathan C Trent
Sylvester Comprehensive Cancer Center, University of Miami
Career Start Year 1995
Number of shared co-authors 7
Brian P Rubin
Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic
Career Start Year 1994
Number of shared co-authors 6
Udo Rudloff
Center for Cancer Research, National Cancer Institute
Career Start Year 1994
Number of shared co-authors 0
Rebecca A Gladdy
Mount Sinai Hospital
Career Start Year 1994
Number of shared co-authors 2
Stefan Sleijfer
Erasmus MC Cancer Institute, University Medical Center Rotterdam
Career Start Year 1994
Number of shared co-authors 1
John M Kane
Roswell Park Comprehensive Cancer Center
Career Start Year 1993
Number of shared co-authors 4
Enrique de Alava
Servicio de Anatomia Patologica. Hospital Universitario Virgen del Rocio.
Career Start Year 1992
Number of shared co-authors 2
Funda Meric-Bernstam
University of Texas MD Anderson Cancer Center
Career Start Year 1990
Number of shared co-authors 10
Emile E Voest
The Netherlands Cancer Institute
Career Start Year 1989
Number of shared co-authors 2
Luc Dirix
GZA Ziekenhuizen Campus Sint-Augustinus, University of Antwerp
Career Start Year 1988
Number of shared co-authors 2
Jose A Lopez-Martin
Hospital Universitario 12 de Octubre
Career Start Year 1988
Number of shared co-authors 0
David M Loeb
Children's Hospital at Montefiore.
Career Start Year 1986
Number of shared co-authors 2
Kenneth R Hess
The University of Texas MD Anderson Cancer Center
Career Start Year 1986
Number of shared co-authors 6
Seth M Steinberg
Center for Cancer Research, National Cancer Institute
Career Start Year 1984
Number of shared co-authors 3
Antonio Jimeno
University of Colorado School of Medicine
Career Start Year 1974
Number of shared co-authors 1

Collaborators

Fritz C Eilber
University of California, Los Angeles David Geffen School of Medicine
Co-authored papers 65
Scott D Nelson
University of California-Los Angeles
Co-authored papers 55
Sarah M Dry
Jonsson Comprehensive Cancer Center, University of California los angeles
Co-authored papers 48
Robert M Hoffman
Co-authored papers 46
Bartosz Chmielowski
Jonsson Comprehensive Cancer Center, University of California Los Angeles
Co-authored papers 29
Nicholas M Bernthal
University of California-Los Angeles
Co-authored papers 15
Noah Federman
University of California los angeles
Co-authored papers 14
Anusha Kalbasi
Stanford Cancer Institute, Stanford School of Medicine
Co-authored papers 13
Michael Bouvet
Co-authored papers 8
Joseph G Crompton
Jonsson Comprehensive Cancer Center, University of California los angeles
Co-authored papers 7
Jane Yanagawa
David Geffen School of Medicine, University of California Los Angeles
Co-authored papers 7
Susan V Bukata
University of California
Co-authored papers 6
Antoni Ribas
University of California Los Angeles (university of california los angeles)
Co-authored papers 5
Jomjit Chantharasamee
Siriraj Hospital, Mahidol University
Co-authored papers 4
Michael L Steinberg
University of California los angeles
Co-authored papers 3
Mitchell Kamrava
Cedars Sinai Medical Center
Co-authored papers 3
Francis J Hornicek
Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami
Co-authored papers 3
Siraj M Ali
Foundation Medicine
Co-authored papers 2
Daniel D Von Hoff
Co-authored papers 2
Johannes Czernin
university of california los angeles
Co-authored papers 2
Owen N Witte
University of California los angeles
Co-authored papers 2
Thinzar M Lwin
City of Hope National Medical Center
Co-authored papers 2
Rong-Rong Huang
Stomatology Hospital, Zhejiang University School of Medicine
Co-authored papers 2
David Elashoff
David Geffen School of Medicine at University of California los angeles
Co-authored papers 2
Frederick R Eilber
University of California-Los Angeles
Co-authored papers 2
Nicholas J Jackson
St Thomas' Hospital
Co-authored papers 1
Wassim Abida
Memorial Sloan Kettering Cancer Center
Co-authored papers 1
Hannah Cox
Co-authored papers 1
Peyton J Tebon
Co-authored papers 1
Nasrin Tavanaie
David Geffen School of Medicine, University of California los angeles
Co-authored papers 1
Release 1.2